LABP insider filings
Landos Biopharma, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-05-23. Screen LABP transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for LABP between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Landos Biopharma, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-05-23 | 4 | Callori Fred — Director | Disposition to issuer (D): 1,800 (derivative) · Disposition to issuer (D): 1,800 (derivative) · Disposition to issuer (D): 1,800 (derivative) | EDGAR |
| 2024-05-23 | 4 | Batycky Alka — Director | Disposition to issuer (D): 3,600 (derivative) | EDGAR |
| 2024-05-23 | 4 | Garabedian Christopher Nishan — Director | Disposition to issuer (D): 1,800 (derivative) · Disposition to issuer (D): 1,800 (derivative) · Disposition to issuer (D): 1,800 (derivative) | EDGAR |
| 2024-05-23 | 4 | Cataldi Fabio — Chief Medical Officer | Disposition to issuer (D): 48,813 (derivative) · Disposition to issuer (D): 18,449 (derivative) · Disposition to issuer (D): 39,999 (derivative) | EDGAR |
| 2024-05-23 | 4 | Oakes Gregory — Chief Executive Officer, Director | Disposition to issuer (D): 54,454 (derivative) · Disposition to issuer (D): 47,529 (derivative) · Disposition to issuer (D): 167,724 (derivative) | EDGAR |
| 2024-05-23 | 4 | Adsett Roger — Director | Disposition to issuer (D): 1,800 (derivative) · Disposition to issuer (D): 1,800 (derivative) · Disposition to issuer (D): 3,600 (derivative) | EDGAR |
| 2024-05-23 | 4 | Girao Tiago — Director | Disposition to issuer (D): 1,800 (derivative) · Disposition to issuer (D): 1,800 (derivative) · Disposition to issuer (D): 1,800 (derivative) | EDGAR |
| 2024-05-23 | 4 | MAYLEBEN TIMOTHY M — Director | Disposition to issuer (D): 1,800 (derivative) · Disposition to issuer (D): 1,800 (derivative) | EDGAR |
| 2024-03-04 | 4 | Cataldi Fabio — Chief Medical Officer | Grant/award (A): 21,138 (derivative) @ $0 | EDGAR |
| 2024-03-04 | 4 | Oakes Gregory — Chief Executive Officer, Director | Grant/award (A): 54,454 (derivative) @ $0 | EDGAR |
| 2023-06-01 | 4 | Batycky Alka — Director | Grant/award (A): 3,600 (derivative) @ $0 | EDGAR |
| 2023-05-24 | 4 | Garabedian Christopher Nishan — Director | Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2023-05-24 | 4 | Callori Fred — Director | Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2023-05-24 | 4 | Adsett Roger — Director | Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2023-05-24 | 4 | Girao Tiago — Director | Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2023-05-24 | 4 | MAYLEBEN TIMOTHY M — Director | Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2023-03-02 | 4 | Bassaganya-Riera Josep — 10% owner | Sale (S): 3,470,736 · Sale (S): 467,306 · Sale (S): 496,527 · Sale (S): 500,000 · Sale (S): 786,299 | EDGAR |
| 2023-03-02 | 4 | Cataldi Fabio — Chief Medical Officer | Grant/award (A): 184,500 (derivative) @ $0 · Grant/award (A): 276,750 (derivative) @ $0 | EDGAR |
| 2023-03-02 | 4 | Oakes Gregory — Chief Executive Officer, Director | Grant/award (A): 475,300 (derivative) @ $0 | EDGAR |
| 2023-03-02 | 4 | Truesdell Patrick — Vice President and Controller | Grant/award (A): 99,600 (derivative) @ $0 · Grant/award (A): 99,600 (derivative) @ $0 | EDGAR |
| 2023-01-11 | 4 | PERCEPTIVE ADVISORS LLC — 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD — 10% owner Perceptive Xontogeny Venture Fund, LP — 10% owner Perceptive Xontogeny Venture Fund II, LP — 10% owner EDELMAN JOSEPH — 10% owner | Purchase (P): 27,272,727 (derivative) @ $0.54 · Purchase (P): 3,636,363 (derivative) @ $0.54 | EDGAR |
| 2022-09-27 | 4 | RTW INVESTMENTS, LP — 10% owner WONG RODERICK — 10% owner | Sale (S): 300,000 @ $0.69 | EDGAR |
| 2022-09-07 | 4 | Cataldi Fabio — Chief Medical Officer | Grant/award (A): 400,000 (derivative) @ $0 | EDGAR |
| 2022-08-09 | 4 | Bassaganya-Riera Josep — 10% owner | Gift (G): 500,000 @ $0 · Gift (G): 500,000 @ $0 | EDGAR |
| 2022-06-22 | 4 | Oakes Gregory — Chief Executive Officer, Director | Grant/award (A): 1,677,251 (derivative) @ $0 | EDGAR |
| 2022-06-22 | 4 | MAYLEBEN TIMOTHY M — Director | Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2022-06-09 | 4 | Callori Fred — Director | Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2022-06-09 | 4 | Garabedian Christopher Nishan — Director | Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2022-06-09 | 4 | Adsett Roger — Director | Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2022-06-09 | 4 | Girao Tiago — Director | Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2022-05-18 | 4 | Callori Fred — Director | Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2022-05-18 | 4 | Garabedian Christopher Nishan — Director | Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2022-05-18 | 4 | Girao Tiago — Director | Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2022-03-10 | 4 | Adsett Roger — Director | Grant/award (A): 36,000 (derivative) @ $0 | EDGAR |
| 2021-12-21 | 4 | BITAR PATRICIA L — Interim CFO | Grant/award (A): 87,513 (derivative) @ $0 | EDGAR |
| 2021-12-21 | 4 | MAYLEBEN TIMOTHY M — Interim CEO, Director | Grant/award (A): 253,485 (derivative) @ $0 | EDGAR |
| 2021-12-20 | 4 | Bassaganya-Riera Josep — 10% owner | Gift (G): 58,651 @ $0 · Sale (S): 24,301 @ $5.11 · Sale (S): 36,000 @ $4.84 · Sale (S): 33,194 @ $4.75 | EDGAR |
| 2021-12-15 | 4 | Bassaganya-Riera Josep — 10% owner | Sale (S): 40,000 @ $5.37 · Sale (S): 42,000 @ $5.10 · Sale (S): 43,000 @ $5.02 | EDGAR |
| 2021-12-10 | 4 | Bassaganya-Riera Josep — 10% owner | Sale (S): 11,162 @ $6.26 · Sale (S): 40,000 @ $5.77 | EDGAR |
| 2021-12-08 | 4 | Bassaganya-Riera Josep — 10% owner | Sale (S): 36,000 @ $6.17 · Sale (S): 42,000 @ $6.58 · Sale (S): 25,530 @ $6.65 | EDGAR |
| 2021-12-03 | 4 | Bassaganya-Riera Josep — 10% owner | Sale (S): 32,237 @ $7.01 · Sale (S): 29,861 @ $6.45 · Sale (S): 36,000 @ $6.15 · Gift (G): 934,504 @ $0 · Gift (G): 934,504 @ $0 | EDGAR |
| 2021-12-01 | 4 | Bassaganya-Riera Josep — 10% owner | Sale (S): 15,430 @ $7.58 · Sale (S): 35,000 @ $7.06 | EDGAR |
| 2021-11-18 | 4 | Chauhan Jyoti — ED, Global Clinical Operations | Option exercise (M): 118,054 @ $1.86 · Option exercise (M): 118,054 (derivative) @ $0 | EDGAR |
| 2021-08-31 | 4 | Callori Fred — Director | Grant/award (A): 36,000 (derivative) @ $0 | EDGAR |
| 2021-08-31 | 4 | Xontogeny, LLC — Director | Grant/award (A): 10,709 (derivative) @ $0 | EDGAR |
| 2021-08-31 | 4 | PERCEPTIVE ADVISORS LLC — Director, 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD — Director Perceptive Xontogeny Venture Fund, LP — Director EDELMAN JOSEPH — Director | Grant/award (A): 25,291 (derivative) @ $0 | EDGAR |
| 2021-05-17 | 4 | MAYLEBEN TIMOTHY M — Director | Grant/award (A): 36,000 (derivative) @ $0 | EDGAR |
| 2021-04-12 | 4 | Girao Tiago — Director | Grant/award (A): 36,000 (derivative) @ $0 | EDGAR |
| 2021-02-09 | 4 | Poukalov Konstantin — Director, 10% owner | Purchase (P): 27,453 @ $11.14 · Purchase (P): 34,611 @ $11.38 · Purchase (P): 86,671 @ $12.53 · Purchase (P): 1,771 @ $13.10 · Purchase (P): 64,730 @ $13.80 · Purchase (P): 34,951 @ $14.60 | EDGAR |
| 2021-02-09 | 4 | PERCEPTIVE ADVISORS LLC — Director, 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD — Director, 10% owner Xontogeny, LLC — Director, 10% owner Perceptive Xontogeny Venture Fund, LP — Director, 10% owner EDELMAN JOSEPH — Director, 10% owner | Purchase (P): 27,453 @ $11.14 · Purchase (P): 34,611 @ $11.38 · Purchase (P): 86,671 @ $12.53 · Purchase (P): 1,771 @ $13.10 · Purchase (P): 64,730 @ $13.80 · Purchase (P): 34,951 @ $14.60 | EDGAR |
Recent 8-K events — Landos Biopharma, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2024-05-23 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2024-05-23 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-03-25 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-03-21 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-01-04 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-11-21 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-11-09 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-09-21 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2023-09-14 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-08-09 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=LABP returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs